Skip to main content
. Author manuscript; available in PMC: 2022 Jun 6.
Published in final edited form as: J Sex Med. 2021 Jun 6;18(6):1104–1109. doi: 10.1016/j.jsxm.2021.03.077

Table 3:

Multivariate Cox Proportional Hazards Model of Time to Revision stratified by Infection versus Noninfection (adjusted for patient age, year of implant, obesity status, smoking status, hypertension, hyperlipidemia, and Peyronie’s Disease) and times to revision for both infected and non-infected revisions.

IPP Revision
with Infection		 IPP Revision
without infection		 Time to Revision
(Infected)		 Time to Revision
(Non-infected)
Hemoglobin A1c
(%)		 HR (adj) HR (adj) months
(median, range)		 months
(median, range)
<6.0 ref ref 3.54 (0.48 - 19.20) 6.60 (0.36 - 88.32)
6.0-6.9 1.40 (0.75 - 2.60) 0.87 (0.56 - 1.34) 2.52 (0.84 - 31.92) 7.68 (0.12 - 70.56)
7.0 - 7.9 1.76 (0.88 - 3.51) 1.22 (0.76 - 1.95) 2.04 (0.72 - 39.72) 10.32 (1.32 - 95.76)
8.0 – 10.0 2.70 (1.42 - 5.13) 0.58 (0.31 - 1.11) 3.00 (0.12 - 16.32) 14.52 (2.52 - 101.28)
>10.0 4.88 (2.42 - 9.84) 0.34 (0.11 - 1.12) 1.26 (0.24 - 14.04) 7.44 (2.16 - 10.80)